Cargando…

Prevalence of impaired renal function and determinants in the southwest of Iran

BACKGROUND: Chronic kidney disease (CKD) is a growing global health problem with faster progression in developing countries such as Iran. Here we aimed to evaluate the prevalence and determinants of CKD stage III+. METHODS: This research is part of the Khuzestan Comprehensive Health Study (KCHS), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvand, Saba, Abolnezhadian, Farhad, Alatab, Sudabeh, Mohammadi, Zahra, Hayati, Fatemeh, Noori, Mohammad, Danehchin, Leila, Paridar, Yousef, Cheraghian, Bahman, Rahimi, Zahra, Hariri, Sanam, Masoudi, Sahar, Mard, Seyed Ali, Shayesteh, Ali Akbar, Poustchi, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353841/
https://www.ncbi.nlm.nih.gov/pubmed/34376157
http://dx.doi.org/10.1186/s12882-021-02484-x
_version_ 1783736486496043008
author Alvand, Saba
Abolnezhadian, Farhad
Alatab, Sudabeh
Mohammadi, Zahra
Hayati, Fatemeh
Noori, Mohammad
Danehchin, Leila
Paridar, Yousef
Cheraghian, Bahman
Rahimi, Zahra
Hariri, Sanam
Masoudi, Sahar
Mard, Seyed Ali
Shayesteh, Ali Akbar
Poustchi, Hossein
author_facet Alvand, Saba
Abolnezhadian, Farhad
Alatab, Sudabeh
Mohammadi, Zahra
Hayati, Fatemeh
Noori, Mohammad
Danehchin, Leila
Paridar, Yousef
Cheraghian, Bahman
Rahimi, Zahra
Hariri, Sanam
Masoudi, Sahar
Mard, Seyed Ali
Shayesteh, Ali Akbar
Poustchi, Hossein
author_sort Alvand, Saba
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) is a growing global health problem with faster progression in developing countries such as Iran. Here we aimed to evaluate the prevalence and determinants of CKD stage III+. METHODS: This research is part of the Khuzestan Comprehensive Health Study (KCHS), a large observational population-based cross-sectional study in which 30,041 participants aged 20 to 65 were enrolled. CKD was determined with estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m(2), based on two equations of Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). The multivariate logistic regression was used to evaluate the CKD stage III+ determinants. RESULTS: Prevalence of CKD stage III+ is estimated to be 7.1, 5.5, and 5.4% based on MDRD, CKD-EPI, and combination of both equations, respectively. More than 89% of CKD subjects aged higher than 40 years. In regression analysis, age more than 40 years had the strongest association with CKD stage III+ probability (OR: 8.23, 95% CI: 6.91–9.18). Higher wealth score, hypertension, High-Density Lipoprotein levels less than 40 mg/dl, and higher waist to hip ratio were all associated with CKD stage III+ while Arab ethnicity showed a protective effect (OR: 0.69, 95% CI: 0.57–0.78). CONCLUSION: Our findings provide detailed information on the CKD stage III+ and its determinants in the southwest region of Iran. Due to strong association between age and CKD stage III+, within a few decades we might expect a huge rise in the CKD prevalence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02484-x.
format Online
Article
Text
id pubmed-8353841
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83538412021-08-11 Prevalence of impaired renal function and determinants in the southwest of Iran Alvand, Saba Abolnezhadian, Farhad Alatab, Sudabeh Mohammadi, Zahra Hayati, Fatemeh Noori, Mohammad Danehchin, Leila Paridar, Yousef Cheraghian, Bahman Rahimi, Zahra Hariri, Sanam Masoudi, Sahar Mard, Seyed Ali Shayesteh, Ali Akbar Poustchi, Hossein BMC Nephrol Research BACKGROUND: Chronic kidney disease (CKD) is a growing global health problem with faster progression in developing countries such as Iran. Here we aimed to evaluate the prevalence and determinants of CKD stage III+. METHODS: This research is part of the Khuzestan Comprehensive Health Study (KCHS), a large observational population-based cross-sectional study in which 30,041 participants aged 20 to 65 were enrolled. CKD was determined with estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m(2), based on two equations of Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). The multivariate logistic regression was used to evaluate the CKD stage III+ determinants. RESULTS: Prevalence of CKD stage III+ is estimated to be 7.1, 5.5, and 5.4% based on MDRD, CKD-EPI, and combination of both equations, respectively. More than 89% of CKD subjects aged higher than 40 years. In regression analysis, age more than 40 years had the strongest association with CKD stage III+ probability (OR: 8.23, 95% CI: 6.91–9.18). Higher wealth score, hypertension, High-Density Lipoprotein levels less than 40 mg/dl, and higher waist to hip ratio were all associated with CKD stage III+ while Arab ethnicity showed a protective effect (OR: 0.69, 95% CI: 0.57–0.78). CONCLUSION: Our findings provide detailed information on the CKD stage III+ and its determinants in the southwest region of Iran. Due to strong association between age and CKD stage III+, within a few decades we might expect a huge rise in the CKD prevalence. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02484-x. BioMed Central 2021-08-10 /pmc/articles/PMC8353841/ /pubmed/34376157 http://dx.doi.org/10.1186/s12882-021-02484-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Alvand, Saba
Abolnezhadian, Farhad
Alatab, Sudabeh
Mohammadi, Zahra
Hayati, Fatemeh
Noori, Mohammad
Danehchin, Leila
Paridar, Yousef
Cheraghian, Bahman
Rahimi, Zahra
Hariri, Sanam
Masoudi, Sahar
Mard, Seyed Ali
Shayesteh, Ali Akbar
Poustchi, Hossein
Prevalence of impaired renal function and determinants in the southwest of Iran
title Prevalence of impaired renal function and determinants in the southwest of Iran
title_full Prevalence of impaired renal function and determinants in the southwest of Iran
title_fullStr Prevalence of impaired renal function and determinants in the southwest of Iran
title_full_unstemmed Prevalence of impaired renal function and determinants in the southwest of Iran
title_short Prevalence of impaired renal function and determinants in the southwest of Iran
title_sort prevalence of impaired renal function and determinants in the southwest of iran
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353841/
https://www.ncbi.nlm.nih.gov/pubmed/34376157
http://dx.doi.org/10.1186/s12882-021-02484-x
work_keys_str_mv AT alvandsaba prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT abolnezhadianfarhad prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT alatabsudabeh prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT mohammadizahra prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT hayatifatemeh prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT noorimohammad prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT danehchinleila prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT paridaryousef prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT cheraghianbahman prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT rahimizahra prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT haririsanam prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT masoudisahar prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT mardseyedali prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT shayestehaliakbar prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran
AT poustchihossein prevalenceofimpairedrenalfunctionanddeterminantsinthesouthwestofiran